Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CU Study Suggests Link Between Tumor Suppressors and Starvation Survival

Published: Tuesday, May 14, 2013
Last Updated: Tuesday, May 14, 2013
Bookmark and Share
A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division, it also can help make cells more fit by allowing them to fend off stress.

CU-Boulder Professor Min Han said the research team was interested in how a common tumor suppressor gene known as Retinoblastoma 1, or Rb, behaved under conditions of starvation. The question is important, said Han, because it may help researchers understand why many cancer cells are more susceptible to starvation or fasting than ordinary cells.

Han and his team studied a popular lab organism called C. elegans, a translucent nematode smaller than an eyelash. Many of the C. elegans genes have similar, corresponding human genes called homologs, and almost all cellular mechanisms found in the nematodes also are found in mammals, including humans, he said.  The team charted changes in the physiology of newly hatched C. elegans in the absence of food to look at the corresponding stress response.

“We found the tumor suppressor Rb is a critical regulator of the starvation response,” said Han, who also is a Howard Hughes Medical Investigator. “Rb is known for doing more than just suppressing cell division associated with cancer -- it carries out a host of other cellular tasks including regulating development.  The new findings by our group and research by other groups suggest organisms survive longer when they encounter starvation by regulating the expression of a large number of genes.”

A paper on the subject was published online May 9 in Current Biology, a publication of Cell Press. The co-authors on the study, Mingxue Cui, Max Cohen and Cindy Teng, are all researchers associated with both CU-Boulder and HHMI. The study was funded by HHMI and the National Institutes of Health.

As part of the study, the researchers monitored the two- to three-week survival time of hundreds of C. elegans hatchlings in an environment with no food, which caused immediate “developmental arrest,” said Han, a professor in CU-Boulder’s molecular, cellular and developmental biology department. “The survival time of the young nematodes is dramatically shorter when the Rb gene is mutated, which causes changes in the activities of multiple cell signaling pathways.”

The study suggests that Rb plays a critical role in maintaining a starvation-induced “transcriptome,” which is the transcription of DNA to corresponding bits of RNA that allow researchers to pinpoint when and where each gene is turned on or off in the cells, he said. Under starved conditions, for example, Rb represses some responses induced by other physical stressors like pathogens and toxins.

Han said the Rb gene is mutated in a large percentage of human cancers. Hundreds of mutations in the RB gene have been identified in people with retinoblastoma, a rare type of eye cancer that usually strikes young children.

“Altogether, these findings identify Rb as a critical regulator of the starvation response and suggest a link between functions of tumor suppressors and starvation survival,” the team wrote in Current Biology. “These results may provide mechanistic insights into why cancer cells are often hypersensitive to starvation treatment.”

There are about 330 HHMI Investigators in the nation, including 15 Nobel laureates and 157 members of the National Academy of Sciences.  Other HHMI Investigators at CU-Boulder include Natalie Ahn, Kristi Anseth, Tom Cech (also a Nobel laureate) and Roy Parker. In addition, HHMI Investigator Lee Niswander is at the University of Colorado Denver School of Medicine.

Founded in 1953 by aviator and industrialist Howard R. Hughes, HHMI is a nonprofit medical research organization that ranks as one of the nation’s largest philanthropies.  In 2012 HHMI spent $800 million for research and $119 million for science education.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

First Atlas Of Airborne Microbes Across US
Bacteria and fungal species were identified from outdoor dust samples collected from all 50 states.
Wednesday, April 22, 2015
Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Thursday, November 13, 2014
Study Finds ‘Microbial Clock’ may Help Determine Time of Death
An intriguing study may provide a powerful new tool in the quiver of forensic scientists attempting to determine the time of death.
Monday, October 21, 2013
Serendipity Points to New Potential Target and Therapy for Melanoma
A University of Colorado Cancer Center describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer.
Friday, December 21, 2012
Study Shows Air Emissions Near Fracking Sites May Pose Health Risk
The report, based on three years of monitoring, found a number of potentially toxic petroleum hydrocarbons in the air near the wells including benzene, ethylbenzene, toluene and xylene.
Tuesday, March 20, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!